Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
3,044,710
-
Share change
-
-219,393
-
Total reported value
-
$1,309,000
-
Put/Call ratio
-
34%
-
Price per share
-
$0.43
-
Number of holders
-
18
-
Value change
-
-$115,201
-
Number of buys
-
8
-
Number of sells
-
9
Institutional Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q3 2022
As of 30 Sep 2022,
IGC Pharma, Inc. - COM NEW (IGC) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,044,710 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, DEARBORN PARTNERS LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Vident Investment Advisory, LLC, MILLENNIUM MANAGEMENT LLC, and BRIDGEWAY CAPITAL MANAGEMENT, LLC.
This page lists
18
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.